A detailed history of Ea Series Trust transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Ea Series Trust holds 98,952 shares of OVID stock, worth $95,983. This represents 0.01% of its overall portfolio holdings.

Number of Shares
98,952
Holding current value
$95,983
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

BUY
$2.53 - $3.89 $250,348 - $384,923
98,952 New
98,952 $325 Million

Others Institutions Holding OVID

About Ovid Therapeutics Inc.


  • Ticker OVID
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 70,419,400
  • Market Cap $68.3M
  • Description
  • Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...
More about OVID
Track This Portfolio

Track Ea Series Trust Portfolio

Follow Ea Series Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ea Series Trust, based on Form 13F filings with the SEC.

News

Stay updated on Ea Series Trust with notifications on news.